771 related articles for article (PubMed ID: 18642356)
1. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2008 Aug; 38(2):1036-45. PubMed ID: 18642356
[TBL] [Abstract][Full Text] [Related]
2. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
[TBL] [Abstract][Full Text] [Related]
3. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Overgaard K; Jakobsen J
J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
[TBL] [Abstract][Full Text] [Related]
4. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Jacob S
Clin Neurophysiol; 2006 Sep; 117(9):2079-84. PubMed ID: 16859987
[TBL] [Abstract][Full Text] [Related]
5. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
[TBL] [Abstract][Full Text] [Related]
6. Dynamic change of proximal conduction in demyelinating neuropathies: a cervical magnetic stimulation combined with maximum voluntary contraction.
Hitomi T; Kaji R; Murase N; Kohara N; Mezaki T; Nodera H; Kawamura T; Ikeda A; Shibasaki H
Clin Neurophysiol; 2007 Apr; 118(4):741-50. PubMed ID: 17317300
[TBL] [Abstract][Full Text] [Related]
7. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy.
Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D
Ann Neurol; 2000 Dec; 48(6):826-32. PubMed ID: 11117538
[TBL] [Abstract][Full Text] [Related]
8. Length dependence in polyneuropathy associated with IgM gammopathy.
Franssen H; Notermans NC
Ann Neurol; 2006 Feb; 59(2):365-71. PubMed ID: 16437567
[TBL] [Abstract][Full Text] [Related]
9. Child neurology: chronic inflammatory demyelinating polyradiculoneuropathy in children.
Markowitz JA; Jeste SS; Kang PB
Neurology; 2008 Dec; 71(23):e74-8. PubMed ID: 19047554
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia.
Kimura A; Yoshino H; Yuasa T
J Neurol Sci; 2005 Apr; 231(1-2):89-93. PubMed ID: 15792827
[TBL] [Abstract][Full Text] [Related]
11. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles.
Sung JY; Kuwabara S; Kaji R; Ogawara K; Mori M; Kanai K; Nodera H; Hattori T; Bostock H
Muscle Nerve; 2004 Jan; 29(1):28-37. PubMed ID: 14694495
[TBL] [Abstract][Full Text] [Related]
12. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome.
Cleland JC; Logigian EL; Thaisetthawatkul P; Herrmann DN
Muscle Nerve; 2003 Aug; 28(2):189-93. PubMed ID: 12872323
[TBL] [Abstract][Full Text] [Related]
13. Activity-dependent conduction block in chronic inflammatory demyelinating polyneuropathy.
Straver DC; van den Berg LH; Franssen H
J Neurol Sci; 2011 Jan; 300(1-2):33-8. PubMed ID: 21035143
[TBL] [Abstract][Full Text] [Related]
14. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
[TBL] [Abstract][Full Text] [Related]
15. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
[TBL] [Abstract][Full Text] [Related]
16. [Interrelationship among nerve conduction velocity, amplitudes of compound muscle and compound nerve action potentials in diabetic neuropathy].
Hasegawa O; Matsumoto S; Iino M; Mori I; Arita T; Baba Y
No To Shinkei; 1999 Oct; 51(10):863-6. PubMed ID: 10553586
[TBL] [Abstract][Full Text] [Related]
17. Neurophysiological evaluation of trigeminal and facial nerves in patients with chronic inflammatory demyelinating polyneuropathy.
Kokubun N; Hirata K
Muscle Nerve; 2007 Feb; 35(2):203-7. PubMed ID: 17063459
[TBL] [Abstract][Full Text] [Related]
18. Prominent cauda equina involvement in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Matsumoto H; Hanajima R; Terao Y; Yugeta A; Hamada M; Shirota Y; Ohminami S; Nakatani-Enomoto S; Tsuji S; Ugawa Y
J Neurol Sci; 2010 Mar; 290(1-2):112-4. PubMed ID: 19900685
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiological changes in neurologically asymptomatic hypothyroid patients: a prospective cohort study.
El-Salem K; Ammari F
J Clin Neurophysiol; 2006 Dec; 23(6):568-72. PubMed ID: 17143145
[TBL] [Abstract][Full Text] [Related]
20. [Study on the latency difference between compound muscle and sensory nerve action potentials].
Hasegawa O; Gondo G; Wada N; Matsumoto S; Mimura E
No To Shinkei; 2001 Jun; 53(6):541-5. PubMed ID: 11436338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
